TAIPEI, Sept. 11, 2024 /PRNewswire/ — Fobeni Healthcom, a joint venture between Fortune 500 giants Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma”, 600196.SS, 02196.HK) and Marubeni Corporation (“Marubeni”, 8002.T), unveiled an innovative food-grade GLP-1 product,…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.